Robert Moskwa1, Azam Ahmed2, and Walter Block1
1Medical Physics, University of Wisconsin-Madison, Madison, WI, United States, 2Neurological Surgery, University of Wisconsin-Madison, Madison, WI, United States
Synopsis
The
international Phase III MISTIE Trial, which used CT-image guidance to position
a catheter at the site of intracerebral hemorrhage (ICH) failed
to meet its clinical endpoint for all patients. The
Trial concluded that improved guidance was needed to help a wider set of
neurosurgeons. MR-guidance
of ICH evacuation could meet these needs. We
present an MR-guidance prototype to
provide neurosurgeons with a real-time interface with similar viewpoints as commonly
used in stereotactic operating room settings. The
MR-guidance prototype shows
potential to be a reliable tool to assist as monitoring and guiding
tools and lysing drugs during clot-evacuation procedures.
Introduction
The international Phase III MISTIE Trial,
which used CT-image guidance to position a catheter at the site of
intracerebral hemorrhage (ICH) for periodic clot drainage and infusion of
thrombolytic drugs (Fig. 1), failed to meet its clinical endpoint for all
patients. However, a subset of patients whose interventions left less than 15
ml of residual clot volume showed statistically significant reductions in morbidity
and increased independence[1]. The Trial concluded that improved guidance was needed to
help a wider set of neurosurgeons meet the 15 ml residual volume goal without
endangering rebleeds.
MR-guidance of ICH evacuation could
meet these needs, as envisioned in Figure 1. We have previously presented
methodologies indicated that MR-guidance of lysing blood clots in ex-vivo
models could accelerate clot evacuation while providing the guidance to assure
neurosurgeons that they weren’t interfering with clot boundaries with normal
brain tissue[2]. Co-infused Gd with the clot-busting drugs allowed easy
visualization of the spatial distribution of the clot buster drug (rtPA) within
the clot, as shown in Fig. 2. We present here an MR-guidance prototype that is
designed to allow neurosurgeons to periodically assess and alter the clot
evacuation by manipulating catheter position, adding rtPA, and spatially
visualizing the delivery and distribution of the clot buster with respect to
normal brain tissue. The prototype is designed to provide neurosurgeons with an
interface with similar viewpoints as commonly used in stereotactic operating
room settings using popular commercial surgical workstations, such as the
Medtronic Stealth or Brainlab platforms.Methods
We used the HeartVista RTHawk interventional
platform[3], as it allows us to design the interventional guidance without
knowing specific software constructs or data pathways on the commercial
scanner. RTHawk also allows for the creation of a custom interface and provides
an integrated MRI simulator. Interfaces were created with the purpose of
providing neurosurgeons easy and intuitive access to MRI viewpoints that are
already commonly used in a stereotactic operating room setting. For this work,
these viewpoints included standard axial, sagittal, and coronal views, as well
as two views in the plane of an invasive deice, and one perpendicular to the
device, termed ‘probe’s eye view’. The
standard views are meant to quickly show the clot in relation to well
understood brain viewpoints. The oblique
planes co-linear with the device are designed to show clot lysing drugs
relative to the catheter. The probe’s eye view mimics a standard view used
commonly in neurosurgery.
With the help of RTHawk’s
pre-existing libraries of widgets and pulse sequences, two types of visual
interfaces are demonstrated:
1)
A
4-panel display, where three panels are the reference axial, sagittal, and
coronal views, with the fourth main window allowing for the real-time display
of any through plane selectable by the user from the reference planes. A
real-time spiral GRE sequence is used, where FOV, slice thickness, and flip
angle are allowed to be changed in real-time. Interface is shown in Fig. 3.
2)
A
3-panel display, where each of the three panels are fully adjustable by the
user. This includes selecting any through-plane to visualize, rotating the
image, and selecting parameters in real-time such as TR, TE, and FOV. A
real-time spiral GRE sequence is used as shown in Fig 4. The TE can easily be extended to provide T2*
imaging that highlights clot.
Due to time constraints and
difficulties related to COVID-19 MRI, the prototype results are all from a
simulated phantom.Results
Both interfaces were easy to
prototype and intuitive to use. Data is acquired in real-time until the user
stops acquisition. Viewing any plane during the real-time sequence is possible
and nearly-instantaneous due to the rapid GRE sequences used. As an example, Fig. 3 shows a trajectory of an invasive device on the sagittal plane shown in red.
By using a through-plane tool on the sagittal reference window, a plane
perpendicular to the trajectory is chosen, and is represented on the main view
as an example probe’s eye view. This view will constantly update and can be
changed at any time. Figure 4 shows that two views perpendicular to the device’s
path can be easily displayed (top), all while still displaying the probe’s eye
view (bottom). Furthermore, parameters can be chosen in real-time for
flexibility.Discussion
MR-guidance
holds many advantages over CT in regards to ICH visualization and evacuation. The
flexibility provided by the RTHawk interface allow for rapid prototyping and
feedback from our neurosurgery collaborators. Due to MR-magnet constraints over
the past couple months, integrating on an actual 3T GE scanner has not been
completed yet. After integration, we
plan to first test the real-time visualization system in ex-vivo models of
swine blood and then move to a swine model of ICH using injected blood to
simulate an ICH. Further development on the prototype platform is planned to
create six concurrent visualization planes, similar to the Medtronic Stealth
setup our neurosurgery collaborators use when guiding devices in the
stereotactic OR. Conclusion
The
MR-guidance prototype created using RTHawk shows potential to be a flexible and
reliable tool to assist as monitoring and guiding tools and lysing drugs
during clot-evacuation procedures, potentially for more extensive clot
evacuation while minimizing chances of rebleeds. Acknowledgements
We acknowledge funding support from NIH 1R43NS110164-01A. UW-Madison also receives research support from GE Healthcare. I would also like to thank Eugene Ozhinsky for his help when I was starting out. References
[1] Hanley DF, Thompson
RE, Rosenblum M, Yenokyan G, Lane K, McBee
N, Mayo SW, Bistran-Hall
AJ, Gandhi D, Mould WA, Ullman N, Ali H, Carhuapoma JR, Kase CS, Lees
KR, Dawson J, Wilson A, Betz JF,
Sugar EA, Hao Y, Avadhani R, Caron JL, Harrigan MR, Carlson AP, Bulters
D, LeDoux D, Huang J, Cobb C,
Gupta G, Kitagawa R, Chicoine MR, Patel H, Dodd R, Camarata PJ, Wolfe S,
Stadnik A, Money PL, Mitchell
P, Sarabia R, Harnof S, Barzo P, Unterberg A, Teitelbaum JS, Wang W,
Anderson CS, Mendelow AD,
Gregson B, Janis S, Vespa P, Ziai W, Zuccarello M, Awad IA,
Investigators MI. Efficacy and safety of
minimally invasive surgery with thrombolysis in intracerebral
haemorrhage evacuation (MISTIE III): a
randomised, controlled, open-label, blinded endpoint phase 3 trial.
Lancet. 2019. Epub 2019/02/12. doi:
10.1016/S0140-6736(19)30195-3. PubMed PMID: 30739747.Melander A, Olsson
J, Lindberg G, Ciaria MV, Ariano M,
Strom R, Gibney J, Weiss U, Turner B, O'Gorman P, Watts G,
Powrie J, Crook M, Shaw K, Cummings M.
35th Annual Meeting of the European Association for the Study of
Diabetes : Brussels, Belgium, 28
September-2 October 1999. Diabetologia. 1999;42(Suppl 1):A1-A330. Epub
1999/08/01. doi:
10.1007/BF03375458. PubMed PMID: 27770183.
[2] Moskwa R, Olsen M, et al. Feasibility
and Demonstration of Controlled, Comprehensive Delivery of Clot-Busting Drugs
for MR Image-Guided Intracerebral Clot Evacuation. Poster session presented at:
ISMRM. 27th Annual Conference. 2019 May 14; Montreal, Canada.
[3] Santos JM, Wright GA, Pauly JM.
Flexible real-time magnetic resonance imaging framework. Conf Proc IEEE Eng Med
Biol Soc. 2004;2:1048-51. PubMed PMID: 17271862.